Foundayo
Foundayo is a once-daily tablet from Eli Lilly for chronic weight management in adults with obesity, or adults who are overweight and have at least one weight-related medical condition, used alongside a reduced-calorie diet and increased physical activity. It contains orforglipron, a small-molecule (non-peptide) GLP-1 receptor agonist that can be taken at any time of day, with or without food or water restrictions — no fasting window, no injection, no fridge.
“If you haven't used Foundayo before, 0.8mg is the recommended starting dose.”
Dr. Thush Balan, Chief Medical Officer
£119/ month
0.8mg dosePre-order: order now and your treatment is dispatched as soon as stock arrives, after your prescriber consultation.
Includes your online consultation and prescriber support. Save more on longer plans
Foundayo pricing
One monthly price per dose — pay less on longer plans.
Pre-order — dispatched as soon as Foundayo stock arrives.
0.8mg £119/mo
2.5mg £129/mo
5.5mg £139/mo
9mg £179/mo
14.5mg £199/mo
17.2mg £229/mo
Your dose is confirmed with a prescriber during your online consultation.
Pricing questions
The price shown covers the cost of the medication itself for a one-month supply, including your online consultation, prescriber support, and ongoing care resources.
The initial payment covers the comprehensive online consultation process with a licensed UK prescriber. This ensures our clinical team can dedicate the necessary time to thoroughly review your health information and determine if the treatment is safe and appropriate for you.
If, after the consultation, you decide not to proceed or the prescriber determines you are not eligible for the treatment for safety or medical reasons, you will receive a full refund for the medication cost. The consultation fee portion may be non-refundable to cover the clinician's time.
Foundayo FAQs answered.
In the UK, Foundayo® (orforglipron) is a prescription-only, once-daily oral tablet licensed for weight management. Developed by Eli Lilly, it is the first small-molecule GLP-1 medicine available as a simple daily pill.
Foundayo activates GLP-1 receptors — the same pathway targeted by injectable treatments like Wegovy® and Mounjaro®. It reduces appetite, slows stomach emptying and helps you feel fuller for longer, supporting weight loss alongside a reduced-calorie diet and increased physical activity.
The most common side effects of Foundayo® are gastrointestinal, such as nausea, diarrhoea, vomiting, constipation and indigestion. These are usually mild to moderate and most noticeable when starting treatment or moving up a dose.
Eligibility is determined by a UK-registered prescriber based on your BMI, medical history and health assessment. Foundayo is typically suitable for adults living with obesity, or who are overweight with a weight-related health condition.
Foundayo is not suitable for everyone — including people who are pregnant or breastfeeding, and those with certain thyroid, pancreatic or severe gastrointestinal conditions. Your prescriber will review your full medical history before any prescription is issued.
It is one tablet taken once a day. Treatment starts at a low dose and is increased gradually through six strengths (0.8mg to 17.2mg), with your prescriber confirming each step at your regular check-ins.
Many people notice reduced appetite within the first few weeks, with weight loss building gradually as the dose is increased. Steady, sustainable progress over months is the goal rather than rapid early loss.
Results vary, but clinical trials of orforglipron alongside lifestyle changes have shown substantial average weight loss over several months. Your own results will depend on your dose, diet, activity and how your body responds.
No. All three support weight loss through GLP-1 receptor activity, but Foundayo® (orforglipron) is a once-daily tablet, while Wegovy® (semaglutide) and Mounjaro® (tirzepatide) are once-weekly injections. They are different medicines with different doses and are not interchangeable without clinical guidance.
Yes — many patients switch under clinical supervision. Your clinician will advise on timing and the safest starting dose on the new medicine.
If you miss a dose, skip it and take your next dose at the usual time the following day. Never take two tablets on the same day to catch up.
Swallow one tablet whole, once a day, at whatever time suits you best. Taking it at the same time each day makes it easier to remember.
No — unlike some earlier oral GLP-1 medicines, Foundayo has no food, water or fasting restrictions. You can take it with or without food, at any time of day.
Your consultation and order work exactly as normal. Because Foundayo is newly launched in the UK, your medication is dispatched as soon as stock arrives — we'll keep you updated, and you can message our clinical team at any time.
Eat smaller meals, avoid rich or fatty foods, stay well hydrated and stop eating when you feel full. Side effects usually settle within a few days of starting or increasing a dose — if they persist, message your clinician.
There is no direct interaction, but alcohol adds calories and can worsen nausea or low blood sugar symptoms. If you choose to drink, do so in moderation.
Foundayo may reduce how well oral contraceptive pills are absorbed, particularly when starting treatment or increasing your dose. Your clinician may advise adding a barrier method or switching to a non-oral contraceptive — raise this during your consultation.
No. Foundayo should not be used during pregnancy or breastfeeding, and should be stopped in advance if you are planning a pregnancy. Speak to your clinician about timing.
Combinations may be possible under medical supervision, but doses of other diabetes medicines often need adjusting to reduce the risk of low blood sugar. Always tell your prescriber about every medicine you take.
Foundayo is stored at room temperature — no refrigeration needed. Keep the tablets in their original packaging, away from moisture and out of reach of children.
Yes — Foundayo has no food or water requirements, so it can fit around fasting. Discuss your plans with your clinician so your hydration and meal pattern can be managed safely.
Some weight regain is common after stopping any GLP-1 medicine if habits return to how they were before. Building lasting changes to diet, activity and sleep while on treatment gives you the best chance of keeping weight off.
A balanced, reduced-calorie diet with plenty of protein, fibre and hydration works best. There is no single required diet — your heySlim programme includes guidance to help you build sustainable habits.
Yes — regular activity is encouraged and improves your results. Combining resistance exercise with adequate protein helps preserve muscle while you lose weight.
Mild nausea or stomach upset is common and usually passes. If you experience severe or persistent abdominal pain, repeated vomiting or signs of dehydration, stop taking Foundayo and seek medical advice promptly.
Temporary hair shedding can occur with rapid weight loss from any cause, including GLP-1 treatment. It typically resolves as weight stabilises; adequate protein and nutrients help.
Typically at least four weeks per strength before moving up, and only when your prescriber confirms you're ready. There's no requirement to reach the highest dose — the right dose is the one that works for you with manageable side effects.
Foundayo is licensed for weight management, and eligibility is based on your BMI and overall health rather than the cause of weight gain. Your prescriber will assess whether it is appropriate for your circumstances.
Yes — because it needs no refrigeration or needles, Foundayo is easy to travel with. Keep the tablets in their original packaging and carry them in your hand luggage when flying.
Routine blood tests are not usually required, but your clinician may request them based on your medical history or other medicines. Regular check-ins track your progress and side effects instead.
Most can be taken as normal, but always list every medicine and supplement in your health assessment. Foundayo can affect how some oral medicines are absorbed, so your clinician will flag anything that needs adjusting.
No. Foundayo is not a stimulant — it is a GLP-1 receptor agonist that works with your body's own appetite-regulating hormones, unlike older stimulant-based diet pills.
Complete our secure online consultation. A UK-registered prescriber will review your answers and, if suitable, issue a private prescription — with your order dispatched as soon as Foundayo stock arrives.
Still have questions? Get in touch.